Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Dapt Rivaroxaban'

Dapt Rivaroxaban published presentations and documents on DocSlides.

Rivaroxaban compared with enoxaparin for the prevention of

Rivaroxaban compared with enoxaparin for the prevention of

  • luanne-stotts
  • 21 Slides

Alexander T Cohen . On behalf of the MAGELLAN Ste...

Update on the New Oral Anticoagulants

Update on the New Oral Anticoagulants

  • sherrill-nordquist
  • 39 Slides

Eliot Williams, MD PhD. Division of Hematology &a...

A New Era in Anticoagulation Management

A New Era in Anticoagulation Management

  • debby-jeon
  • 46 Slides

Allyson Sarigianis, Pharm.D.. October 19, 2013. O...

Novel Oral Anticoagulants

Novel Oral Anticoagulants

  • natalia-silvester
  • 88 Slides

(. N. OAC). Dan . Moellentin. , . PharmD. , BCPS,...

Alexander G

Alexander G

  • min-jolicoeur
  • 35 Slides

G. . Turpie. Professor Emeritus of Medicine. McM...

Management of

Management of

  • marina-yarberry
  • 74 Slides

Atrial. Fibrillation. Phillip H. Lam, M.D.. Chie...

Administrative

Administrative

  • phoebe-click
  • 47 Slides

. Principles. of . Vaccination. Prof. Dr. AHMET...

Recent ACS: STEMI, NSTEMI, UA

Recent ACS: STEMI, NSTEMI, UA

  • danika-pritchard
  • 20 Slides

Stabilized 1-7 Days Post-Index Event. Exclusions:...

Oral anticoagulants in the 21

Oral anticoagulants in the 21

  • natalia-silvester
  • 50 Slides

st. century: A practical guide to using newer A...

Dodson Thompson, DO

Dodson Thompson, DO

  • lois-ondreau
  • 40 Slides

Northlakes. Community Clinic. Minong, WI. Novel ...

Two-Year Outcomes of

Two-Year Outcomes of

  • jane-oiler
  • 18 Slides

High Bleeding Risk Patients after Polymer-Free Dr...

A Multicenter Randomized Trial Evaluating Clinically Signif

A Multicenter Randomized Trial Evaluating Clinically Signif

  • ellena-manuel
  • 20 Slides

Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...

R eal-world

R eal-world

  • liane-varnes
  • 20 Slides

EVI. dence. on . S. troke prevention . I. n pati...

New Oral Anticoagulant

New Oral Anticoagulant

  • mitsue-stanley
  • 80 Slides

R2 Patcharee Seesongsom. R2 . Sirada. . Phoja...

Update in the Perioperative and Emergency Management of Nov

Update in the Perioperative and Emergency Management of Nov

  • danika-pritchard
  • 47 Slides

Annelise Gallien, MD FRCPC. Moncton City Hospital...

A Multicenter Randomized Trial Evaluating Clinically Signif

A Multicenter Randomized Trial Evaluating Clinically Signif

  • giovanna-bartolotta
  • 20 Slides

Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...

The Novel Oral Anticoagulants

The Novel Oral Anticoagulants

  • tatyana-admore
  • 47 Slides

Fawaz Altuwaijri. ACEM trainee. Introduction. Cha...

Stroke, Bleeding, and

Stroke, Bleeding, and

  • lois-ondreau
  • 7 Slides

Mortality Risks . in . Elderly Medicare Beneficia...

Sangramento GI associado a PCI

Sangramento GI associado a PCI

  • marina-yarberry
  • 22 Slides

Juan Felipe Castillo Schrul. Residente Hemodinâm...

Rivaroxaban or Aspirin for Extended Treatment of Venous Thr

Rivaroxaban or Aspirin for Extended Treatment of Venous Thr

  • yoshiko-marsland
  • 25 Slides

(EINSTEIN CHOICE). Ryan Sparks, . PharmD. , BCPS....

Trials and Tribulations in VTE:

Trials and Tribulations in VTE:

  • celsa-spraggs
  • 0 Slides

How Do Real-World Data Fit In? . Program Goals. V...

Antiplatelet therapy in CAD

Antiplatelet therapy in CAD

  • alexa-scheidler
  • 0 Slides

Minilecture. Objectives. Indications for Antiplat...

Pharmaceutical Management of Cardiac Medications:

Pharmaceutical Management of Cardiac Medications:

  • pamella-moone
  • 0 Slides

A Look at New Oral Anticoagulants. Linda Wing, . ...

Antiplatelet therapy in CAD

Antiplatelet therapy in CAD

  • celsa-spraggs
  • 0 Slides

Minilecture. Objectives. Indications for Antiplat...

Rapid Reversal of Anticoagulation for Patients with Intracerebral Hemorrhage

Rapid Reversal of Anticoagulation for Patients with Intracerebral Hemorrhage

  • faustina-dinatale
  • 0 Slides

Fred V. Plapp MD PhD. Pathology and Laboratory Me...

Sandy Bartlett, PhD, PharmD

Sandy Bartlett, PhD, PharmD

  • mitsue-stanley
  • 0 Slides

, . BCPS, BCCCP. Associate Professor | Department...

POWER IN NUMBERS: REVISITING EFFICACY & SAFETY OF

POWER IN NUMBERS: REVISITING EFFICACY & SAFETY OF

  • phoebe-click
  • 0 Slides

NOACS IN AF. Where Do We Stand With NOACs in AF ...

A New Era in Anticoagulation Management

A New Era in Anticoagulation Management

  • alexa-scheidler
  • 0 Slides

Allyson Sarigianis, Pharm.D.. October 19, 2013. O...

New Oral Anticoagulants: A Review

New Oral Anticoagulants: A Review

  • phoebe-click
  • 0 Slides

Babak Moini, MD. Veterans Affairs Hospital. Noon ...

Pharmacology of Anticoagulants

Pharmacology of Anticoagulants

  • conchita-marotz
  • 0 Slides

Nathan Culver, . PharmD. , BCPS. anticoagulant Me...

What Has Been Tried and What Is True?

What Has Been Tried and What Is True?

  • celsa-spraggs
  • 0 Slides

What Has Changed?. Less Stent Thrombosis . With. ...

A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban

A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban

  • celsa-spraggs
  • 0 Slides

Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...

Dual Antiplatelet Therapy (DAPT) Duration

Dual Antiplatelet Therapy (DAPT) Duration

  • tatiana-dople
  • 0 Slides

Dilemma: Recent Trials And Guidelines For. Clinic...

CAD/PAD in Primary Care CV Risk in Stable Outpatients

CAD/PAD in Primary Care CV Risk in Stable Outpatients

  • stefany-barnette
  • 0 Slides

Stratified by Baseline CV Risk Category. Aspirin ...

Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary or Peripheral Artery Disease:

Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary or Peripheral Artery Disease:

  • giovanna-bartolotta
  • 15 Slides

Rivaroxaban Plus Aspirin in Patients With and Wit...

Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators

Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators

  • yoshiko-marsland
  • 18 Slides

Dr. Phil Wells on behalf of the EINSTEIN CHOICE ...

Anticoagulation and Thrombosis Management

Anticoagulation and Thrombosis Management

  • pasty-toler
  • 14 Slides

Anticoagulation and Thrombosis Management A Revie...

Evidence-Based Antiplatelet Therapy Across the ACS Spectrum

Evidence-Based Antiplatelet Therapy Across the ACS Spectrum

  • debby-jeon
  • 42 Slides

Evidence-Based Antiplatelet Therapy Across the AC...

September 18, 2018 Andrea Price, MS, CPHQ, RCIS, CCA

September 18, 2018 Andrea Price, MS, CPHQ, RCIS, CCA

  • celsa-spraggs
  • 41 Slides

September 18, 2018 Andrea Price, MS, CPHQ, RCIS, ...

A ssessment of D ual antiplatelet therapy versus

A ssessment of D ual antiplatelet therapy versus

  • stefany-barnette
  • 22 Slides

A ssessment of D ual antiplatelet therapy versus...

Copyright © 2024 DocSlides. All Rights Reserved